{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:16:04Z","timestamp":1771460164789,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.hrthm.2014.05.001","type":"journal-article","created":{"date-parts":[[2014,5,6]],"date-time":"2014-05-06T15:32:06Z","timestamp":1399390326000},"page":"1441-1445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Combination therapy of cilostazol and bepridil suppresses recurrent ventricular fibrillation related to J-wave syndromes"],"prefix":"10.1016","volume":"11","author":[{"given":"Tetsuji","family":"Shinohara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Ebata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reika","family":"Ayabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiro","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunio","family":"Yufu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikiko","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2014.05.001_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jelectrocard.2005.06.006","article-title":"ST-segment elevation in the early repolarization syndrome, idiopathic ventricular fibrillation, and the Brugada syndrome: cellular and clinical linkage","volume":"38","author":"Shu","year":"2005","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.hrthm.2014.05.001_bib2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.hrthm.2009.12.006","article-title":"J wave syndromes","volume":"7","author":"Antzelevitch","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2014.05.001_bib3","first-page":"265","article-title":"Need for definition and standardized clinical evaluation. Consensus statement of the Joint Steering Committees of the Unexplained Cardiac Arrest Registry of Europe and of the Idiopathic Ventricular Fibrillation Registry of the United States","volume":"95","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2014.05.001_bib4","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jacc.2008.10.044","article-title":"Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy","volume":"53","author":"Haissaguerre","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2014.05.001_bib5","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1161\/01.CIR.0000143159.30585.90","article-title":"Efficacy of quinidine in high-risk patients with Brugada syndrome","volume":"110","author":"Belhassen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2014.05.001_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1023\/A:1007779908346","article-title":"Effects of pimobendan on the l-type Ca2+ current and developed tension in guinea-pig ventricular myocytes and papillary muscle: comparison with ibmx, milrinone, and cilostazol","volume":"13","author":"Matsui","year":"1999","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.hrthm.2014.05.001_bib7","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1046\/j.1540-8167.2002.00698.x","article-title":"Prevention of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome","volume":"13","author":"Tsuchiya","year":"2002","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2014.05.001_bib8","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.hrthm.2007.02.014","article-title":"Acute and chronic management in patients with brugada syndrome associated with electrical storm of ventricular fibrillation","volume":"4","author":"Ohgo","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2014.05.001_bib9","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/01.fjc.0000159660.16793.84","article-title":"Repolarization dynamics in patients with idiopathic ventricular fibrillation: pharmacological therapy with bepridil and disopyramide","volume":"45","author":"Sugao","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.hrthm.2014.05.001_bib10","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.hrthm.2006.05.016","article-title":"Characterization of j wave in a patient with idiopathic ventricular fibrillation","volume":"3","author":"Shinohara","year":"2006","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2014.05.001_bib11","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1056\/NEJMoa071968","article-title":"Sudden cardiac arrest associated with early repolarization","volume":"358","author":"Haissaguerre","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2014.05.001_bib12","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.jacc.2013.02.077","article-title":"Quinidine, a life-saving medication for Brugada syndrome, is inaccessible in many countries","volume":"61","author":"Viskin","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2014.05.001_bib13","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.hrthm.2013.07.047","article-title":"Cellular mechanisms underlying the effects of milrinone and cilostazol to suppress arrhythmogenesis associated with Brugada syndrome","volume":"10","author":"Sz\u00e9l","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2014.05.001_bib14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1476-5381.1984.tb16123.x","article-title":"Effects of bepridil on the electrophysiological properties of guinea-pig ventricular muscles","volume":"81","author":"Anno","year":"1984","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.hrthm.2014.05.001_bib15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1254\/jphs.08312FP","article-title":"Effects of antiarrhythmic drugs on the hyperpolarization-activated cyclic nucleotide-gated channel current","volume":"110","author":"Tamura","year":"2009","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.hrthm.2014.05.001_bib16","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/BF00168656","article-title":"Effects of the calcium entry blocker bepridil on repolarizing and pacemaker currents in sheep cardiac Purkinje fibres","volume":"339","author":"Berger","year":"1989","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527114005050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527114005050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:46:49Z","timestamp":1761547609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527114005050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1547527114005050"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2014.05.001","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination therapy of cilostazol and bepridil suppresses recurrent ventricular fibrillation related to J-wave syndromes","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2014.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}